
Taficita 200mg/25mg Tablet
Marketer
Mylan Pharmaceuticals Pvt Ltd - A Viatris Company
Salt Composition
Emtricitabine (200mg) + Tenofovir disoproxil fumarate (25mg)
Overview Taficita 200mg/25mg Tablet
Combivir 200mg/25mg tablets are classified as antiretroviral medications, employed in the management of HIV (human immunodeficiency virus), the causative agent of AIDS (acquired immunodeficiency syndrome). This treatment helps regulate the HIV infection, thereby bolstering immune system function. Crucially, Combivir 200mg/25mg tablets do not cure HIV/AIDS; instead, they reduce the viral load, minimizing the risk of HIV-related complications and potentially extending lifespan. Prophylactic use in high-risk individuals may also be indicated. The medication can be administered alone or alongside other antiretroviral agents, with dosage determined by your physician. Adherence to the prescribed regimen is paramount. Optimal absorption is achieved when taken with food. Consistent, timely medication intake significantly enhances efficacy and mitigates the development of drug resistance. Missed doses should be avoided, and treatment should continue as directed by your doctor. Commonly reported side effects include nausea, diarrhea, headache, insomnia, rash, and vertigo. While generally mild, persistent or bothersome effects warrant medical attention. Long-term use may elevate the risk of osteoporosis; regular exercise and supplementation with calcium and vitamin D, as advised by your doctor, are recommended. Weight gain is a potential side effect. Pre-existing liver, kidney, or bone disorders should be disclosed to your physician before initiating treatment. Regular blood tests to monitor blood cell counts, liver and kidney function are necessary during treatment. Dizziness or drowsiness may impair driving ability. Pregnant or breastfeeding individuals should seek medical counsel. Avoid unprotected sex and the sharing of personal items if HIV-positive. Discuss safe sex practices, such as condom use, with your doctor to prevent HIV transmission.
Primary Ingredients of Taficita 200mg/25mg Tablet
No text provided. Please provide the text you wish to be rephrased.
Uses of Taficita 200mg/25mg Tablet
Human immunodeficiency virus infection
Major Benefits of Taficita 200mg/25mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 200mg/25mg Taficita tablet whole; do not crush, break, or chew it. Administer this medication with a meal.
Common Side effects of Taficita 200mg/25mg Tablet:
- Nausea
- Diarrhea
- Headache
- Depression
- Rash
- Dizziness
- Fatigue
- Vomiting
- Insomnia (difficulty in sleeping)
- Weakness
- Allergic reaction
- Abnormal dreams
- Decreased phosphate level in blood
- Decreased white blood cell count (neutrophils)
- Increased triglyceride level in blood
- Abdominal pain
- Weight loss
- Increased transaminase level in blood
- Increased glucose level in blood
- Elevated levels of serum amylase
- Increased lipase in the blood
- Elevated creatinine kinase
How to use Taficita 200mg/25mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing. Consume Taficita 200mg/25mg tablets with a meal.
How Taficita 200mg/25mg Tablet works:
Each Taficita 200mg/25mg tablet contains Emtricitabine and Tenofovir disoproxil fumarate, two antiretroviral drugs. This combination works by hindering HIV replication, thus lowering the viral load. Simultaneously, it elevates the CD4 T-cell count, bolstering the body's immune response.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Taficita 200mg/25mg Tablet is undetermined. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The use of Taficita 200mg/25mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Taficita 200mg/25mg tablets safely. Available human data indicates minimal infant risk associated with this medication.
DrivingUNSAFE
Using Taficita 200mg/25mg tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Individuals with kidney impairment should use Taficita 200mg/25mg tablets cautiously. Dosage modification of Taficita 200mg/25mg tablets may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Taficita 200mg/25mg tablets in patients with liver conditions is likely safe. Current evidence indicates dose modification may not be necessary, but a physician's consultation is recommended.
What if you forget to take Taficita 200mg/25mg Tablet :
Should you forget a Taficita 200mg/25mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Taficita 200mg/25mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
